NSG 6005 Week 7 Pharmacology Quiz Updated
Exam 2026 WITH Recent Newest Verified And
Well Analyzed Exam Questions (Actual Exam
2026-2027) Correct Detailed & Verified
ANSWERS (100% Accurate Solutions) ALREADY
GRADED A+||NEWEST VERSION Of The Exam
Guarantee Pass!!
When starting a patient with hypothyroidism on thyroid replacement hormones, patient
education would include the following:
A. He or she should feel symptomatic improvement in one to two weeks.
B. Drug-related adverse effects such as lethargy and dry skin may occur.
C. It may take four to eight weeks to get to euthyroid symptomatically and by lab testing.
D. Due to the short half-life of levothyroxine, its doses should not be missed. -
ANSWERS-C. It may take four to eight weeks to get to euthyroid symptomatically and
by lab testing.
The drug recommended as primary prevention of osteoporosis in women over seventy
years old is:
A. Alendronate (Fosamax)
B. Ibandronate (Boniva)
C. Calcium carbonate
D. Raloxifene (Evista) - ANSWERS-A. Alendronate (Fosamax)
Goals of treatment when treating hypothyroidism with thyroid replacement include:
A. Normal TSH and free T4 levels
, B. Resolution of fatigue
C. Weight loss to baseline
D. All of the above - ANSWERS-D. All of the above
Intranasal calcitonin is used in the treatment of osteoporosis. For which patient is
Calcitonin therapy appropriate?
A. Thin, Caucasian perimenopausal women
B. Men over the age of sixty-five years with osteoporosis
C. Women over the age of sixty-five years with osteopenia
D. Women over the age of sixty-five years with severe osteoporosis - ANSWERS-D.
Women over the age of sixty-five years with severe osteoporosis
Bisphosphonates treat or prevent osteoporosis by:
A. Inhibiting osteoclastic activity
B. Fostering bone resorption
C. Enhancing calcium uptake in bones
D. Strengthening the osteoclastic proton pump - ANSWERS-A. Inhibiting osteoclastic
activity
Potentially fatal granulocytopenia has been associated with the treatment of
hyperthyroidism with propylthiouracil. Patients should be taught to report:
A. Tinnitus and decreased salivation
B. Fever and sore throat
C. Hypocalcemia and osteoporosis
D. Laryngeal edema and difficulty swallowing - ANSWERS-C. Hypocalcemia and
osteoporosis
Exam 2026 WITH Recent Newest Verified And
Well Analyzed Exam Questions (Actual Exam
2026-2027) Correct Detailed & Verified
ANSWERS (100% Accurate Solutions) ALREADY
GRADED A+||NEWEST VERSION Of The Exam
Guarantee Pass!!
When starting a patient with hypothyroidism on thyroid replacement hormones, patient
education would include the following:
A. He or she should feel symptomatic improvement in one to two weeks.
B. Drug-related adverse effects such as lethargy and dry skin may occur.
C. It may take four to eight weeks to get to euthyroid symptomatically and by lab testing.
D. Due to the short half-life of levothyroxine, its doses should not be missed. -
ANSWERS-C. It may take four to eight weeks to get to euthyroid symptomatically and
by lab testing.
The drug recommended as primary prevention of osteoporosis in women over seventy
years old is:
A. Alendronate (Fosamax)
B. Ibandronate (Boniva)
C. Calcium carbonate
D. Raloxifene (Evista) - ANSWERS-A. Alendronate (Fosamax)
Goals of treatment when treating hypothyroidism with thyroid replacement include:
A. Normal TSH and free T4 levels
, B. Resolution of fatigue
C. Weight loss to baseline
D. All of the above - ANSWERS-D. All of the above
Intranasal calcitonin is used in the treatment of osteoporosis. For which patient is
Calcitonin therapy appropriate?
A. Thin, Caucasian perimenopausal women
B. Men over the age of sixty-five years with osteoporosis
C. Women over the age of sixty-five years with osteopenia
D. Women over the age of sixty-five years with severe osteoporosis - ANSWERS-D.
Women over the age of sixty-five years with severe osteoporosis
Bisphosphonates treat or prevent osteoporosis by:
A. Inhibiting osteoclastic activity
B. Fostering bone resorption
C. Enhancing calcium uptake in bones
D. Strengthening the osteoclastic proton pump - ANSWERS-A. Inhibiting osteoclastic
activity
Potentially fatal granulocytopenia has been associated with the treatment of
hyperthyroidism with propylthiouracil. Patients should be taught to report:
A. Tinnitus and decreased salivation
B. Fever and sore throat
C. Hypocalcemia and osteoporosis
D. Laryngeal edema and difficulty swallowing - ANSWERS-C. Hypocalcemia and
osteoporosis
